The TCR-based Therapies Summit is Dedicated to Supercharging TCR Design, Translation & Manufacturing Strategy for Solid Tumor Success Running digitally for 2021, the 2nd TCR-based Therapies Summit is the leading industry-focused meeting dedicated […]

The inaugural Next Generation Gene Therapy Vectors meeting is dedicated to overcoming the current immunogenicity, toxicity and manufacturability challenges facing the field by pioneering the next generation of superior delivery vectors. Industry […]

With commitments to advancing your preclinical and translational oncology research, we are delighted to bring the 9th annual PREDiCT: Tumor Models Cell Therapy Summit to your screens in July. See best-in-class tumor […]

SMi are proud to announce the 5th annual conference: Pre-Filled Syringes West Coast 2020 14-15 June 2021 San Diego, CA, USA Hyatt Regency Mission Bay www.prefilled-syringes-westcoast.com/pjwl Assessing Device Development and […]

As investments and collaborations hit a record high, the RNAi therapeutics industry continues to rapidly expand. With RNAi drugs prevailing as a therapy with huge potential against liver diseases, exciting […]

Skin microbiome products have been gaining more momentum in the last few years with more brands starting to develop products, and personal care giants either starting to develop their own product […]

SMi’s 4th Pharmaceutical Microbiology West Coast Conference Novel approaches and best practices for tackling current industry contamination control challenges SMi’s 4th Annual Conference Pharmaceutical Microbiology West Coast NEW DATE: June 17 – […]

In its most exciting year yet the field of oncolytic virotherapy has seen the highest number of clinical read-outs, the emergence of next generation viruses, and never-before-seen combination therapies. Now […]

Welcome to the Digital HER2-Targeted Therapies Summit 2021 - The First Conference Focused on Exploring New Frontiers of HER2 as a Pan-Tumor Target HER2 expressing patients are experiencing drug resistance, […]

CPhI & P-MEC China has launched the “E-Trade Season 2021” from March to June 2021 to provide the pharmaceutical industry with online learning and trading opportunities. One of the themed […]

Now in its 3rd year, the Blood-Brain Barrier Summit is the industry’s definitive blood-brain barrier conference, focused exclusively on evaluating innovative approaches to tackling the single biggest challenge for CNS drug developers. Building […]

Close the Clinical Gap, Discover the Next Generation of Microbiome-based Therapeutics, and Establish New Partnerships to Accelerate Your Research The advancing scientific and clinical landscape mixed with the high-quality audience […]

Since the start of the 20th century, there have been three major waves of innovation in drug discovery. We are now at the start of a fourth wave, multispecific medicines, that […]

Returning to the digital stage this summer, the 2nd JAK Inhibitors Drug Development Summit brings you the only dedicated JAK inhibitor conference that will allow you to utilize the knowledge […]

The 3rd Annual Cell Engager Summit is the only industry-led forum dedicated to developing multi-specific cell engaging therapies in liquid and solid tumor indications, accelerating early discovery innovation into the clinic. This […]

The inaugural ARDS Drug Development Summit will bring 60+ biopharma leaders together to discover how the rise of SARS-CoV-2 ARDS, emergence of novel targets, and the past 12 months of […]

The mRNA-Based Therapeutics Summit will unite the world leaders developing mRNA therapeutics to discuss learnings, challenges and future directions concerning translation and manufacturing of your novel mRNA modality. From mRNA vaccine development for infectious […]

The Non-Small Cell Lung Cancer (NSCLC) Drug Development Summit is the definitive industry-led forum for drug development in the largest solid tumor indication. This is a strategic conference designed to bring drug development teams […]

Develop & implement your practical roadmap to migrate your GxP regulated applications to the cloud with regulatory, security & partner selection guidance.  Establish robust documentation practices to maintain CFR 11 […]

Returning digitally in 2021, the 2nd Annual Gene Therapy for Neurological Disorders Europe meeting will possibly be your last chance to attend a European meeting without the airmiles! Focusing on the industry’s challenges […]

In-House Impact: Life Sciences is a new type of forum, designed for and by legal leaders in the Life Sciences, to help legal teams move from enterprise defenders to enablers of […]

In the fight against emerging coronavirus variants, the need for long-lasting immunity is greater than ever… which is why the field is looking beyond antibodies and turning to T cells. […]

In the context of dramatically increasing food allergy incidence and a breakthrough approval in the field, the Next Generation Food Allergy Drug Development Summit will unite large pharma and innovative biotechs to […]

The 2nd Gene Therapy Immunogenicity Summit is the industry’s definitive forum enabling you to better modulate, measure and predict immune response to your gene therapy candidate. In the context of ever-increasing gene therapy […]

Translating Scientific Findings of the Skin Microbiome into Commercially Viable Therapeutics & Cosmetic Products That Improve Skin Health With improvements in the tools and technologies that enable deeper analysis of […]

The inaugural virtual Prostate Cancer Drug Development Summit lands at a crucial time as the first and only dedicated conference for large pharma, biotech and pioneering academics to unite under a common and ambitious […]

The excitement surrounding integrins has been growing over the past few years, culminating in recent clinical success, innovative biology and medicinal chemistry advancements blazing the way to tackle previously undruggable disease modalities through novel integrin […]

The 2nd Annual Biomarkers for Alzheimer’s Disease Summit is the industry’s only digital forum dedicated to sharing innovations in identifying new novel biomarkers and solving the challenges of developing clinically validated […]

New this year, the Neuropathic Pain Therapeutics digital summit is the only meeting for large pharma, biotech and pioneering academics addressing the industry’s key challenges of understanding the underlying pathophysiology […]

With 5 currently approved PI3K inhibitors in the market, and countless investments, M&As and candidates entering the clinical stages, the PI3K pathways space has experienced significant growth in recent years. […]